Search research articles
Contact Us
Filters
Showing results (61-70 of 133) with videos related to
Page
of 14
Sort By:
Cancer Chemotherapy and Pharmacology
|
February 14, 2019
Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation
Ou Yamaguchi, Kyoichi Kaira, Atsuto Mouri, et al.
Analytical Chemistry
|
June 19, 2025
Beyond the Nucleus: Cytoplasmic Dominance in Follicular Thyroid Carcinoma Detection Using Single-Cell Raman Imaging across Multiple Devices
Aurelien Pelissier, Kosuke Hashimoto, Kentaro Mochizuki, et al.
Thoracic Cancer
|
February 1, 2021
Effectiveness of EGFR-TKI rechallenge immediately after PD-1 blockade failure
Kyoichi Kaira, Kunihiko Kobayashi, Ayako Shiono, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
November 19, 2024
Clinical significance of visual cardiac <sup>18</sup>F-FDG uptake in advanced non-small cell lung cancer
Kosuke Hashimoto, Kyoichi Kaira, Hisao Imai, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Raman Study on Lipid Droplets in Hepatic Cells Co-Cultured with Fatty Acids
Pradjna N Paramitha, Riki Zakaria, Anisa Maryani, et al.
Scientific Reports
|
September 15, 2020
Tumor metabolic volume by <sup>18</sup>F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50
Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, et al.
Journal of Clinical Medicine
|
March 12, 2020
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer
Kosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi, et al.
Respiratory Medicine Case Reports
|
December 24, 2025
G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report
Naohito Hashimoto, Kyoichi Kaira, Tatsuhiko Uno, et al.
Cancer Immunology, Immunotherapy : CII
|
December 19, 2025
Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer
Shota Takei, Ayako Shiono, Satoshi Yamasaki, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 133) with videos related to
Sort By:
Page
of 14
Cancer Chemotherapy and Pharmacology
|
February 14, 2019
Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation
Ou Yamaguchi, Kyoichi Kaira, Atsuto Mouri, et al.
Analytical Chemistry
|
June 19, 2025
Beyond the Nucleus: Cytoplasmic Dominance in Follicular Thyroid Carcinoma Detection Using Single-Cell Raman Imaging across Multiple Devices
Aurelien Pelissier, Kosuke Hashimoto, Kentaro Mochizuki, et al.
Thoracic Cancer
|
February 1, 2021
Effectiveness of EGFR-TKI rechallenge immediately after PD-1 blockade failure
Kyoichi Kaira, Kunihiko Kobayashi, Ayako Shiono, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2019
Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer
Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
November 19, 2024
Clinical significance of visual cardiac <sup>18</sup>F-FDG uptake in advanced non-small cell lung cancer
Kosuke Hashimoto, Kyoichi Kaira, Hisao Imai, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Raman Study on Lipid Droplets in Hepatic Cells Co-Cultured with Fatty Acids
Pradjna N Paramitha, Riki Zakaria, Anisa Maryani, et al.
Scientific Reports
|
September 15, 2020
Tumor metabolic volume by <sup>18</sup>F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50
Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, et al.
Journal of Clinical Medicine
|
March 12, 2020
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer
Kosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi, et al.
Respiratory Medicine Case Reports
|
December 24, 2025
G-CSF-producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report
Naohito Hashimoto, Kyoichi Kaira, Tatsuhiko Uno, et al.
Cancer Immunology, Immunotherapy : CII
|
December 19, 2025
Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer
Shota Takei, Ayako Shiono, Satoshi Yamasaki, et al.
Page
of 14